Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitro

Li,Yaqing; Xu,Wulin; Yan,Jianping; Xia,Yingjie; Gu,Chao; Ma,Yingyu; Tao,Houquan

doi:10.3892/ijmm.2014.1705

Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitro

Authors:
- Yaqing Li
- Wulin Xu
- Jianping Yan
- Yingjie Xia
- Chao Gu
- Yingyu Ma
- Houquan Tao
View Affiliations

Affiliations: Department of Respiratory Medicine, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China
Published online on: March 19, 2014 https://doi.org/10.3892/ijmm.2014.1705
Pages: 1507-1513

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Type II alveolar epithelial cells (AECII) play a key role in maintaining normal alveolar homeostasis and repair. AECII derived from exogenous stem cells may provide novel treatment options for distal lung diseases. In this study, to explore whether amniotic fluid-derived mesenchymal stem cells (AFMSCs) may be induced to differentiate into AECII in vitro, AFMSCs were isolated from 15 independent samples of amniotic fluid, in which CD29, CD44, CD73, CD90, CD105 and CD166 were significantly expressed, but the expression of CD14, CD19, CD34 and CD45 was negative. Octamer-binding transcription factor 4 (OCT4) at both the mRNA and protein level was also significantly expressed in the AFMSCs. We demonstrate that AFMSCs cannot be induced to differentiate into AECII using KnockOut™ serum replacement (KOSR) only. Surfactant protein (SP)A and SPC mRNA expression in the differentiated AFMSCs was significantly induced by the appropriate combination of KOSR, activin A and small airway basal medium (SABM). However, SPA and SPC expression was negative with an inappropriate induction. Lamellar bodies were observed only in the cells which were appropriately induced by KOSR, activin A and SABM. Thus, these results indicate that AFMSCs may be induced to differentiate into AECII-like cells in vitro with the use of the appropriate induction medium, including KOSR, activin A and SABM, suggesting that that AFMSCs have the potential for use in lung regenerative therapy.

View Figures

View References

1	Whitsett JA, Wert SE and Weaver TE: Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 61:105–119. 2010. View Article : Google Scholar : PubMed/NCBI
2	Hoffman AM and Ingenito EP: Alveolar epithelial stem and progenitor cells: emerging evidence for their role in lung regeneration. Curr Med Chem. 19:6003–6008. 2012. View Article : Google Scholar : PubMed/NCBI
3	Tsuji T, Aoshiba K and Nagai A: Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration. 80:59–70. 2010. View Article : Google Scholar
4	Miyake Y, Kaise H, Isono K, Koseki H, Kohno K and Tanaka M: Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II Cells. J Immunol. 178:5001–5009. 2007. View Article : Google Scholar : PubMed/NCBI
5	Corti M, Brody AR and Harrison JH: Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol. 14:309–315. 1996. View Article : Google Scholar : PubMed/NCBI
6	Ehrhardt C, Kim KJ and Lehr CM: Isolation and culture of human alveolar epithelial cells. Methods Mol Med. 107:207–216. 2005.PubMed/NCBI
7	Fujino N, Kubo H, Suzuki T, et al: Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab Invest. 91:363–378. 2011. View Article : Google Scholar : PubMed/NCBI
8	Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS and Yeqhiazarians Y: Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy. 12:807–817. 2010. View Article : Google Scholar : PubMed/NCBI
9	Muguruma K and Sasai Y: In vitro recapitulation of neural development using embryonic stem cells: from neurogenesis to histogenesis. Dev Growth Differ. 54:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
10	Samadikuchaksaraei A and Bishop AE: Derivation and characterization of alveolar epithelial cells from murine embryonic stem cells in vitro. Methods Mol Biol. 330:233–248. 2006.PubMed/NCBI
11	Wang D, Haviland DL, Burns AR, Zsiqmond E and Wetsel RA: A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 104:4449–4454. 2007. View Article : Google Scholar : PubMed/NCBI
12	Wang D, Morales JE, Calame DG, Alcorn JL and Wetsel RA: Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther. 18:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
13	Sugarman J: Human stem cell ethics: beyond the embryo. Cell Stem Cell. 2:529–533. 2008. View Article : Google Scholar : PubMed/NCBI
14	Tsai MS, Lee JL, Chang YJ and Hwang SM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 19:1450–1456. 2004. View Article : Google Scholar : PubMed/NCBI
15	Sessarego N, Parodi A, Podestà M, et al: Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica. 93:339–346. 2008. View Article : Google Scholar : PubMed/NCBI
16	Joo S, Ko IK, Atala A, Yoo JJ and Lee SJ: Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res. 35:271–280. 2012. View Article : Google Scholar : PubMed/NCBI
17	Hartmann K, Raabe O, Wenisch S and Arnhold S: Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retina-like cells. Am J Stem Cells. 2:108–118. 2013.PubMed/NCBI
18	Sun H, Feng K, Hu J, Soker S, Atala A and Ma PX: Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials. 31:1133–1139. 2010. View Article : Google Scholar : PubMed/NCBI
19	Carraro G, Perin L, Sedrakyan S, et al: Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 26:2902–2911. 2008. View Article : Google Scholar : PubMed/NCBI
20	Perin L, Sedrakyan S, Da Sacco S and De Filippo R: Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol. 86:85–99. 2008. View Article : Google Scholar : PubMed/NCBI
21	De Coppi P, Bartsch G Jr, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 25:100–106. 2007.PubMed/NCBI
22	Roubelakis MG, Trohatou O and Anagnou NP: Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int. 2012:1078362012. View Article : Google Scholar : PubMed/NCBI
23	Benavides OM, Petsche JJ, Moise KJ Jr, Johnson A and Jacot JG: Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A. 18:1123–1131. 2012. View Article : Google Scholar : PubMed/NCBI
24	Tondeur S, Assou S, Nadal L, Hamamah S and De Vos J: Biology and potential of human embryonic stem cells. Ann Biol Clin (Paris). 66:241–247. 2008.(In French).
25	Sisson TH, Mendez M, Choi K, et al: Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med. 181:254–263. 2010. View Article : Google Scholar : PubMed/NCBI
26	Kuwano K: Epithelial cell apoptosis and lung remodeling. Cell Mol Immunol. 4:419–429. 2007.
27	Zhao CZ, Fang XC, Wang D, Tang FD and Wang XD: Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease. Respir Med. 104:1391–1395. 2010. View Article : Google Scholar : PubMed/NCBI
28	Antonucci I, Pantalone A, Tete S, Salini V, Borlongan CV, Hess D and Stuppia L: Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des. 18:1846–1863. 2012.PubMed/NCBI
29	Rippon HJ, Polak JM, Qin M and Bishop AE: Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells. 24:1389–1398. 2006. View Article : Google Scholar : PubMed/NCBI
30	Kubo A, Shinozaki K, Shannon JM, et al: Development of definitive endoderm from embryonic stem cells in culture. Development. 131:1651–1662. 2004. View Article : Google Scholar : PubMed/NCBI
31	Massagué J and Gomis RR: The logic of TGFbeta signaling. FEBS Lett. 580:2811–2820. 2006.PubMed/NCBI
32	Cao Y, Siegel D and Knöchel W: Xenopus POU factors of subclass V inhibit activin/nodal signaling during gastrulation. Mech Dev. 123:614–625. 2006. View Article : Google Scholar : PubMed/NCBI
33	Hansson M, Olesen DR, Peterslund JM, et al: A late requirement for Wnt and FGF signaling during activin-induced formation of foregut endoderm from mouse embryonic stem cells. Dev Biol. 330:286–304. 2009. View Article : Google Scholar : PubMed/NCBI